Ralph R. Vassallo

Scottsdale Research Institute (United States)

Also affiliated with Vitalant

Business, Management and AccountingMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “It's time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4”.

It's time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4

Transfusion(2020)10.1111/trf.15741

N/A

0DataRank · unranked

56 citations

Gregory A. Denomme, John T. Queenan, Susan T. Johnson, Margaret Keller, Connie M. Westhoff +6 more

The evolution of COVID‐19 vaccination within a US blood center

Transfusion(2021)10.1111/trf.16579

N/A

0DataRank · unranked

2 citations

Hany Kamel, Larry J. Dumont, Marjorie D. Bravo, Ralph R. Vassallo

Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients

Blood Advances(2024)10.1182/bloodadvances.2024014143

N/A

0DataRank · unranked

9 citations

Matthew Tanner, Abdullah Alswied, Danny Youngs, Josefine Bribiesca Rodriguez, Thejaswi Bikkani +13 more